RESUMEN
AIM: To analyze clinical profile and management of patients with nonvalvular atrial fibrillation treated with rivaroxaban in clinical practice according to age and to ascertain rates of thromboembolic and bleeding events during rivaroxaban therapy. METHODS: Retrospective study of nonvalvular atrial fibrillation patients that started rivaroxaban therapy between May 2013 and February 2017 in the cardiology department of two hospitals from Huesca, Spain. RESULTS: A total of 137 patients (mean age 78.2 ± 8.9 years; CHA2DS2-VASc 3.5 ± 1.3; HAS-BLED 1.6 ± 0.7) were included. Comorbidity was common. After a mean duration of treatment of 30.5 ± 17.2 months, no strokes were reported. Rates of transient ischemic attack, major bleeding and intracranial bleeding were low. CONCLUSION: In this cohort of elderly and highly comorbid patients treated with rivaroxaban, rates of thromboembolic and bleeding events were low.
Asunto(s)
Fibrilación Atrial/tratamiento farmacológico , Inhibidores del Factor Xa/uso terapéutico , Hemorragia/epidemiología , Rivaroxabán/uso terapéutico , Accidente Cerebrovascular/prevención & control , Tromboembolia/epidemiología , Factores de Edad , Anciano , Anciano de 80 o más Años , Fibrilación Atrial/complicaciones , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pautas de la Práctica en Medicina , Estudios Retrospectivos , España , Accidente Cerebrovascular/etiologíaRESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Adulto , Arteritis de Takayasu/diagnóstico , Pericarditis/diagnóstico , Dolor en el Pecho/etiología , Angiografía Coronaria , Enfermedades Reumáticas/complicaciones , Antiinflamatorios no Esteroideos/uso terapéuticoRESUMEN
Intramyocardial dissecting hematoma is an infrequent complication of subacute myocardial infarction. Pathological findings consist of a cavity filled with blood, the outer wall of which is the myocardium and pericardium and the inner wall, which faces the ventricular cavity, is part of the myocardium and endocardium. There is scarce information on the subject and the management of these patients continues to be debated. However, there is a certain preference for surgical repair of the defect. Cases in which conservative treatment is a therapeutic option have been reported. We report the case of a patient with an intramyocardial dissecting hematoma after acute anterolateral myocardial infarction who was treated conservatively and achieved a satisfactory outcome in the intermediate-to-long term period.
Asunto(s)
Cardiomiopatías/terapia , Hematoma/terapia , Infarto del Miocardio/complicaciones , Cardiomiopatías/etiología , Hematoma/etiología , Humanos , Masculino , Persona de Mediana EdadRESUMEN
El hematoma disecante intramiocárdico es una complicación infrecuente de la fase subaguda del infarto agudo de miocardio. El hallazgo anatomopatológico es una cavidad sanguínea limitada exteriormente por miocardio y pericardio, y hacia la cavidad ventricular por el resto del miocardio y el endocardio. Existe cierta controversia respecto a la actitud a seguir y, aunque hay cierta preferencia por el tratamiento quirúrgico de reparación del defecto, se han descrito casos en los que el seguimiento médico podría ser una opción válida. Presentamos el caso de un hematoma disecante intramiocárdico secundario a un infarto agudo de miocardio anterolateral que se trató de forma conservadora, con una evolución satis-factoria a medio-largo plazo (AU)
